Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Histology Reveals Characteristics of Superimposed Bacterial Ulcerative Colitis

By LabMedica International staff writers
Posted on 23 Jan 2014
Biopsy specimens have been examined for histologic features suggestive of Clostridium difficile infection in patients with ulcerative colitis.

In patients with acutely symptomatic ulcerative colitis, it is important to determine whether the underlying cause of the disease is due to a C. More...
difficile infection or may arise due to other infectious organisms and or bowel ischemia.

Pathologists at St Michael’s Hospital (Toronto, ON, Canada) examined nine patients with ulcerative colitis who had colonic biopsy specimens taken during a symptomatic flare that coincided with positive C. difficile (C. difficile+) tests. They also examined 28 controls that were biopsied during an ulcerative colitis flare, but tested negative for C. difficile. The scientists reviewed the histological slides for evidence of pseudomembranes, ischemic-like changes, degree of colitis, and lamina propria hemorrhage. Pseudomembranes are not real membranes: they represent necrotic debris attached to the colonic wall and may vaguely resemble a volcanic eruption, when examined microscopically.

Stool testing was performed using the C. difficile Tox A/B II enzyme immunoassay (EIA) (Techlab; Blacksburg, VA, USA). The results were analyzed with a dual-wavelength spectrometer at 450 nm and 620 nm. In the patients who had a positive C. difficile+ test, four of nine (44.4%) had microscopic pseudomembranes compared with only 11% in controls who were C. difficile negative, which was statistically significant. The investigators found that other histologic and clinical features were not predictive.

The authors concluded that although the presence of microscopic pseudomembranes suggests C. difficile infection in patients with ulcerative colitis, sensitivity and specificity were poor; biopsy findings do not reliably detect this infection in patients with ulcerative colitis. However, the authors propose that histologic findings of microscopic pseudomembranes should also prompt testing for C. difficile if not already performed.

Ulcerative colitis is a form of inflammatory bowel disease (IBD). It is a disease of the colon that includes characteristic ulcers, or open sores. The main symptom of active disease is usually constant diarrhea mixed with blood, of gradual onset. IBD is often confused with irritable bowel syndrome. The study was published in the December 2013 issue of the American Journal of Clinical Pathology.

Related Links:

St Michael’s Hospital
Techlab



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Prefilled Tubes
Prefilled 5.0ml Tubes
New
Total Laboratory Automation Solution
SATLARS Mini T8
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.